Highlight Therapeutics, a portfolio company of Columbus Venture Partners, and the CNIO launch their seventh clinical trial in advanced skin cancer

by Columbus Venture Partners

The Columbus Venture Partners team, strategic investor in the development of BO-112, celebrates this new clinical milestone as a validation of the company’s scientific and business strategy, while a...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Palacios Alimentación acquires Ñaming,...

by Green Arrow Capital

During the period of investment by GAC and Unigrains Iberia, Ñaming h...

Photos Stream